ReviewHeart rhythm O22025
Catheter ablation of macro-reentrant atrial tachycardia in adults with Ebstein anomaly: A narrative review.
Review in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Improving survival rates of patients with Ebstein anomaly have increased the relevance of catheter ablation of macro-reentrant atrial tachycardia (MRAT). Our objectives were, first, to present a case report and, second, to provide a comprehensive review. A search of articles providing detailed information on adults with Ebstein anomaly who underwent catheter ablation of MRAT was performed. PubMed was queried using "Ebstein" and "ablation" as Medical Subject Headings terms, followed by a review of references and citations. Of the 56 patients included in the final review, which included the case report patient, 40 patients (71%) had only typical atrial flutter and 2 patients (4%) had left atrial involvement. The American Heart Association and American College of Cardiology Adult Congenital Heart Disease Anatomic and Physiological classification was not reported in any of the retrieved articles. Pre-procedural imaging localizing the coronary sinus ostium on the ventricular side of a tricuspid valve prosthesis may indicate the need to perform catheter ablation on the ventricular side to achieve bi-directional block across the cavotricuspid isthmus. Long-term recurrence of atrial tachyarrhythmias occurred in 6 of 23 patients (26.1%) where it was reported. In conclusion, catheter ablation is a viable option for adults with Ebstein anomaly and MRAT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.